ClinConnect ClinConnect Logo
Search / Trial NCT01964105

3D Breast Imaging for Cosmetic and Reconstructive Breast Surgery

Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Oct 16, 2013

Trial Information

Current as of May 20, 2025

Completed

Keywords

Hypomastia Augmentation Breast 3 D Breast Q

ClinConnect Summary

Consultation for primary breast augmentation involves clear communication between patient and surgeon to select the implant and manage expectations. Tissue-based planning strategies rely on tissue characteristics and measurements to produce safe and reproducible aesthetic outcomes. The implementation of sizers in the preoperative consultation and a greater emphasis on patient aesthetic goals have also proven to be favorable strategies. Recently, many plastic surgeons have started to incorporate three-dimensional (3D) photography and computer simulation into their preoperative consultation p...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Age 18 years or older
  • Scheduled for elective breast augmentation cosmetic procedure.
  • Exclusion Criteria:
  • Breast reconstruction for malignancy
  • Cognitively unable to provide informed consent.

About Washington University School Of Medicine

Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.

Locations

Saint Louis, Missouri, United States

Patients applied

0 patients applied

Trial Officials

Terence M Myckatyn, MD, FACS

Principal Investigator

Washington University School of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials